
Bupromat 150mg Tablet ER
Marketer
Matteo Healthcare Pvt Ltd
Salt Composition
Bupropion (150mg)
Overview Bupromat 150mg Tablet ER
Extended-release Bupromat 150mg tablets treat depression and nicotine dependence. The medication achieves this by boosting brain neurotransmitters, promoting relaxation and calming effects. Bupromat 150mg ER can be administered with or without food, consistently at the same time daily. Complete the prescribed course, even with symptom improvement; abruptly ceasing treatment may exacerbate symptoms. Potential side effects include sleep disturbances, allergic reactions, concentration difficulties, perspiration, headaches, nausea, vomiting, dry mouth, dizziness, and drowsiness. Avoid activities demanding alertness, such as driving, while experiencing these effects. Most side effects are transient. Consult your physician for persistent or bothersome side effects. Prior to commencing treatment, disclose any seizure history or alcohol consumption. Report any significant mood shifts or suicidal ideation to your doctor immediately.
Primary Ingredients of Bupromat 150mg Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Bupromat 150mg Tablet ER
Tobacco dependence and depressive disorder
Major Benefits of Bupromat 150mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Bupromat 150mg Extended-Release tablet whole; do not crush, chew, or break it. While this medication can be taken with or without food, consistent timing is recommended.
Common Side effects of Bupromat 150mg Tablet ER:
- Insomnia (difficulty in sleeping)
- Allergic reaction
- Impaired concentration
- Sweating
- Headache
- Nausea
- Vomiting
- Dizziness
- Dryness in mouth
- Taste change
- Abdominal pain
- Agitation
- Anxiety
- Fever
- Constipation
- Tremors
How to use Bupromat 150mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bupromat 150mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.
How Bupromat 150mg Tablet ER works:
Extended-release Bupromat 150mg tablets alleviate depression by boosting neurotransmitter concentrations, thereby improving mood regulation. The precise mechanism by which it aids smoking cessation remains unclear.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Bupromat 150mg extended-release tablets and alcohol may lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Bupromat 150mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCAUTION
Extended-release Bupromat 150mg tablets require careful consideration during lactation. Mothers should discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Extended-release Bupromat 150mg tablets can induce adverse effects that impair driving capabilities. These effects may include dizziness, lightheadedness, reduced concentration, and impaired judgment, potentially compromising safe driving.
KidneyCAUTION
Extended-release Bupromat 150mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Bupromat 150mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Bupromat 150mg Extended-Release tablets cautiously, potentially requiring dosage modification. Medical supervision is necessary, with close monitoring for adverse reactions.
What if you forget to take Bupromat 150mg Tablet ER :
Omit any missed Bupromat 150mg Extended-Release Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Bupromat 150mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Propiophenone Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | Norepinephrine and dopamine reuptake inhibitor |
